Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths among children younger than 5 years of age worldwide. The 7-valent pneumococcal conjugate vaccine (PCV7) is currently ...

Contrary to current thinking, the group of serotypes of Streptococcus pneumoniae responsible for most invasive pneumococcal disease worldwide is conserved across regions, according to new research.

Vaxcyte (NASDAQ:PCVX) executives used a presentation at an annual biotech summit to highlight progress across the company’s ...

Findings presented at IDWeek 2025 underscore the importance of considering serotypes that disproportionately impact adults in the U.S. and show greater resistance to commonly prescribed antibiotics ...

Scientists led by a team from Duke-NUS Medical School have identified three distinct serotypes of SARS-related coronaviruses, marking the need for vaccines that can provide broad-spectrum protection ...

Twenty-two months after a petition was filed requesting that USDA’s Food Safety and Inspection Service (FSIS) declare certain “outbreak” serotypes of Salmonella to be per se adulterants in meat and ...

The 20-valent pneumococcal conjugate vaccine (PCV20, or Prevnar 20) produced a non-inferior immune response in adults to the 13-valent vaccine (PCV13, or Prevnar 13), with an adequate safety profile, ...

The FDA approved a 21-valent pneumococcal conjugate vaccine (Capvaxive) for preventing invasive pneumococcal disease and pneumococcal pneumonia in adults, Merck announced on Monday. Specifically ...

Adeno-associated virus (AAV) vectors are highly efficient for liver-targeted gene delivery in murine models and show promise in early phase human clinical trials. This efficiency is capsid-dependent ...

New research shows how poultry vaccination programs successfully combat Salmonella, with surprising insights into infection sources and prevention.